Anne Plasterer - Newalta Executive Director, Investor Relations
Director
Anne Plasterer is Executive Director, Investor Relations of Newalta
| Phone | 403-806-7000 |
| Web | http://www.newalta.com |
Newalta Management Efficiency
The company has return on total asset (ROA) of (1.78) % which means that it has lost $1.78 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (23.35) %, meaning that it generated substantial loss on money invested by shareholders. Newalta's management efficiency ratios could be used to measure how well Newalta manages its routine affairs as well as how well it operates its assets and liabilities.The company has accumulated 268.26 M in total debt with debt to equity ratio (D/E) of 217.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Newalta has a current ratio of 0.86, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Newalta until it has trouble settling it off, either with new capital or with free cash flow. So, Newalta's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Newalta sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Newalta to invest in growth at high rates of return. When we think about Newalta's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Mitchell Klipper | Steven Madden | 60 | |
| Ravi Sachdev | Steven Madden | 41 | |
| Craig Rydin | PVH Corp | 68 | |
| Philip Coelho | Catalyst Pharmaceuticals | 74 | |
| Robert Moore | Rocky Brands | 66 | |
| Curtis Loveland | Rocky Brands | 67 | |
| Jefferson Gramm | Tandy Leather Factory | 41 | |
| Michael Brown | Regeneron Pharmaceuticals | 77 | |
| Bonnie Bassler | Regeneron Pharmaceuticals | 55 | |
| Bruce Maggin | PVH Corp | 72 | |
| G Haning | Rocky Brands | 65 | |
| Alfred Gilman | Regeneron Pharmaceuticals | 72 | |
| Joseph Goldstein | Regeneron Pharmaceuticals | 77 | |
| Gene Haning | Rocky Brands | 65 | |
| Richard Daly | Catalyst Pharmaceuticals | 57 | |
| Marc TessierLavigne | Regeneron Pharmaceuticals | 58 | |
| Louis Martin | Tandy Leather Factory | 47 | |
| Arthur Ryan | Regeneron Pharmaceuticals | 75 | |
| Mark Angus | Tandy Leather Factory | 53 | |
| Shannon Greene | Tandy Leather Factory | 48 | |
| Christine Poon | Regeneron Pharmaceuticals | 65 | |
Management Performance
| Return On Equity | -23.35 | |||
| Return On Asset | -1.78 |
Newalta Leadership Team
Elected by the shareholders, the Newalta's board of directors comprises two types of representatives: Newalta inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Newalta. The board's role is to monitor Newalta's management team and ensure that shareholders' interests are well served. Newalta's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Newalta's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Alan Cadotte, CEO and President and Non Independent Director | ||
| Linda Dietsche, Vice President - Finance | ||
| Mike Nerbas, Vice President U.S | ||
| Bryne Gramlich, Vice President - Heavy Oil | ||
| Michael Borys, CFO and Executive VP | ||
| Paul Kleinen, Senior Vice President - Engineering and Technical Solutions | ||
| Troy McElgunn, Sr. VP of Operations | ||
| Richard Pinder, Independent Director | ||
| Susan Rose, Independent Director | ||
| Michael Starzer, Independent Director | ||
| Gordon Pridham, Independent Director | ||
| Anne Plasterer, Executive Director, Investor Relations | ||
| Robert MacDonald, Independent Director | ||
| Robert Gemmell, Independent Director | ||
| Colin Merrick, Vice President - Corporate Services | ||
| Laurie Tugman, Independent Director | ||
| Chris Barnes, Vice President - Corporate Development | ||
| Peter Dugandzic, Executive VP of Corporate Services | ||
| John Barkhouse, CEO and President and Director | ||
| Harvey Doerr, Independent Director | ||
| Thomas Ryley, Independent Director | ||
| Took Whiteley, Sr. VP of Corporate Devel. and General Counsel | ||
| Raymond Milligan, Independent Director | ||
| Douglas Pecharsky, Sr. VP of Operations |
Newalta Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Newalta a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -23.35 | |||
| Return On Asset | -1.78 | |||
| Profit Margin | (17.84) % | |||
| Operating Margin | (8.16) % | |||
| Current Valuation | 346.36 M | |||
| Shares Outstanding | 52.2 M | |||
| Price To Earning | (0.51) X | |||
| Price To Book | 0.69 X | |||
| Price To Sales | 0.27 X | |||
| Revenue | 185.94 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Newalta Pink Sheet
If you are still planning to invest in Newalta check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Newalta's history and understand the potential risks before investing.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |